Announcement on Completion of 1st Subject Enrollment in Phase I Clinical Trials of PZH2113 Capsules

About this update from Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A

Announcement on Completion of 1st Subject Enrollment in Phase I Clinical Trials of PZH2113 Capsules The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A